Tandem Diabetes Care (TNDM) Net Margin Growth (5y) (2018 - 2026)
Tandem Diabetes Care (TNDM) Net Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.13 Bn | 557.61 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -466.00 |
| Dec 31, 2025 | -1,030.00 |
| Sep 30, 2025 | -87.00 |
| Jun 30, 2025 | 495.00 |
| Mar 31, 2025 | -4,051.00 |
| Dec 31, 2024 | -217.00 |
| Sep 30, 2024 | -645.00 |
| Jun 30, 2024 | -1,226.00 |
| Mar 31, 2024 | 1,255.00 |
| Dec 31, 2023 | -2,009.00 |
| Sep 30, 2023 | 5,630.00 |
| Jun 30, 2023 | 2,192.00 |
| Mar 31, 2023 | -1,670.00 |
| Dec 31, 2022 | 1,644.00 |
| Sep 30, 2022 | 2,459.00 |
| Jun 30, 2022 | 8,115.00 |
| Mar 31, 2022 | 10,318.00 |
| Dec 31, 2021 | 5,116.00 |
| Sep 30, 2021 | 23,406.00 |
| Jun 30, 2021 | 7,605.00 |